Is vitamin B complex good for sickle cell?
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
133 Citations | An effective vaccine against B19 might make an important contribution to the management of sickle cell disease. |
| Both compounds may therefore be of value for the treatment of sickle cell disease. | |
11 Citations | The result suggests, but not conclusively, that supplementation of sickle cell |
| Compounds of this type may develop useful agents in the therapy of sickle cell anemia. | |
123 Citations | These data form the basis for a clinical trial application for treating sickle cell disease. |
Related Questions
Does taking vitamin B affect depression?5 answersTaking vitamin B, specifically B12, can have a significant impact on depression. Research indicates that vitamin B12 supplementation is associated with a reduced risk of depression. Studies have shown that higher consumption of vitamin B12 can buffer the relationship between depressive symptoms and daytime sleepiness, potentially counteracting the effects of depression. Additionally, dietary intake of vitamin B1, B2, B6, and B12 has been inversely associated with the risk of depression, with higher intakes correlating with a lower risk of developing depression. Therefore, incorporating vitamin B, especially B12, through supplementation or dietary sources, may play a role in managing and potentially preventing depression.
What is the effect of breast feeding sickle cell disease children?5 answersBreastfeeding has a significant impact on children with Sickle Cell Disease (SCD). Research shows that exclusive breastfeeding for a longer duration and delayed weaning are associated with improved anthropometric indicators in SCD children, leading to better growth outcomes. Additionally, early identification of SCD through newborn screening has improved survival rates by preventing sepsis and strokes, while treatments like hydroxyurea have reduced painful crises and transfusion needs in pediatric SCD patients. However, challenges exist for women with SCD during pregnancy and childbirth, with increased risks of adverse maternal outcomes, necessitating comprehensive nursing care to ensure healthy birth outcomes. Furthermore, nutritional interventions like omega-3 fatty acid supplementation have shown positive effects on the nutritional intake and growth parameters of SCD children, improving their caloric intake and body mass index.
Why molecular structure is important through Hemoglobin and Sickle Cell Disease?4 answersThe molecular structure of hemoglobin is important in understanding and treating sickle cell disease (SCD). SCD is caused by a genetic mutation in the hemoglobin molecule, resulting in the formation of abnormal HbS aggregates that polymerize under reduced oxygen tension. This polymerization leads to the deformation of red blood cells and the clinical manifestations of SCD, including chronic hemolytic anemia and vaso-occlusion. Research on the solubility and kinetics of HbS polymerization has provided insights into the pathogenesis of SCD and guided drug development for treating the disease. Additionally, understanding the molecular structure of hemoglobin has led to the use of hydroxyurea to elevate fetal hemoglobin in SCD, which has shown clinical benefits. Overall, studying the molecular structure of hemoglobin has been crucial in unraveling the mechanisms underlying SCD and developing therapeutic strategies for the disease.
How molecular structure is important through Hemoglobin and Sickle Cell Disease?4 answersThe molecular structure of hemoglobin is crucial in understanding sickle cell disease (SCD). SCD is caused by a single amino acid substitution in the beta chain of hemoglobin, resulting in the formation of HbS aggregates under reduced oxygen tension. The polymerization of deoxygenated HbS leads to the characteristic sickling of red blood cells (RBCs). This process is driven by O2 tension and intracellular HbS concentration. The sickling of RBCs is associated with a complex network of cellular changes, contributing to the inflammatory vasculopathy and potential organ damage in SCD. Understanding the molecular pathogenesis of SCD has paved the way for the development of therapeutic strategies targeting HbS polymerization. Additionally, the role of erythrocyte dehydration in cell sickling has been identified, as increased cellular HbS concentration enhances the polymerization tendency of HbS. Overall, the molecular structure of hemoglobin plays a crucial role in the pathophysiology and treatment of SCD.
Why molecular structure importantly affect Hemoglobin and Sickle Cell Disease?3 answersThe molecular structure of hemoglobin plays a crucial role in the development of sickle cell disease (SCD). SCD is caused by a genetic mutation that results in the substitution of glutamic acid with valine in the hemoglobin molecule. This mutation leads to the polymerization of deoxygenated sickle hemoglobin (HbS) into long strands, causing the characteristic sickle-shaped red blood cells. The polymerization of HbS is influenced by various non-covalent interactions between amino acid residues, such as hydrophobic and electrostatic interactions. The formation of HbS fibers and their subsequent growth contribute to the pathogenesis of SCD. Additionally, the concentration of HbS within the red blood cells and the dehydration of these cells also affect the polymerization tendency of HbS. Understanding the molecular mechanisms underlying HbS polymerization is crucial for developing effective therapeutic strategies for SCD.
What is the relationship between oxidative stress and sickle cell disease?5 answersOxidative stress is closely related to sickle cell disease (SCD). SCD is characterized by abnormal sickle hemoglobin (HbS) production, which leads to repeated polymerization and depolymerization of Hb, causing oxidative stress. This oxidative stress plays a key role in the pathophysiology of SCD, leading to hemolysis, vessel occlusion, and organ damage. Studies have shown that SCD patients have decreased levels of antioxidants such as catalase (CAT), glutathione peroxidase (G-Px), and reduced glutathione (GSH), while the levels of lipid peroxidation product malondialdehyde (MDA) are increased. Additionally, SCD patients exhibit alterations in antioxidant indices and increased oxidative stress, which are associated with vaso-occlusive crisis (VOC). The adhesive properties of sickle red blood cell (RBC) subpopulations are also influenced by oxidative stress, leading to increased adhesion to laminin. Understanding oxidative stress in SCD can help develop targeted antioxidant therapies to prevent organ complications in these patients.